AC-262536 NEW
| Price | $41 | $89 | $152 |
| Package | 10mg | 25mg | 50mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-11 |
Product Details
| Product Name: AC-262536 | CAS No.: 870888-46-3 |
| Purity: 99.88% | Supply Ability: 10g |
| Release date: 2026/05/11 |
Product Introduction
Bioactivity
| Name | AC-262536 |
| Description | AC-262536 is a selective androgen receptor (SAR) modulator and exhibits potent agonist activity at the androgen receptor. It has partial agonist activity with respect to testosterone and suppresses luteinizing hormone. |
| In vitro | AC-262536 inhibits dihydroxytestosterone (DHT)-induced proliferation of LNCaP in a dose-dependent manner. The effects are significant with 100 nM, and reaches a plateau with 1 μM[2]. |
| In vivo | In male sprague-dawley rats, administration of AC-262536 (subcutaneous injection, once daily for 14 consecutive days) significantly decreased LH levels by about 40% at the 3 mg/kg dose. At the 10 and 30 mg/kg doses, the effects of AC-262536 were significantly stronger than Testosterone Propionate (TP) : 1.91±0.32 ng/mL and 1.53±0.34 ng/mL vs. 3.12±0.69 ng/mL, respectively[2]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween-80+45% Saline : 1 mg/mL (3.59 mM), Sonication is recommended. DMSO : 50 mg/mL (179.63 mM), Sonication is recommended. |
| Keywords | SARM | receptor | non-steroidal | modulator | Inhibitor | inhibit | AndrogenReceptor | Androgen Receptor | androgen | anabolic | AC-262536 | AC 262536 |
| Inhibitors Related | Dehydroisoandrosterone 3-acetate | Bicalutamide | 2-Ethylhexyl trans-4-methoxycinnamate | S-23 | Enzalutamide | Octinoxate | Testosterone propionate | Allura Red AC | Sunset Yellow FCF | Ostarine | 2-sec-Butylphenol | Flutamide |
| Related Compound Libraries | Nuclear Receptor Compound Library | Bioactive Compound Library | Anti-Prostate Cancer Compound Library | Endocrinology-Hormone Compound Library | Bioactive Compounds Library Max | Covalent Inhibitor Library | Anti-Cancer Compound Library | Transcription Factor-Targeted Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1.00 |
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-06-26 | |
|
VIP3Y
|
Shandong Hanjiang Chemical Co., Ltd
|
2026-06-25 | ||
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2026-06-23 | ||
| $7500.00 |
VIP1Y
|
Rongchuang International
|
2026-06-04 | |
| $101.00 |
VIP3Y
|
Henan Fengda Chemical Co., Ltd
|
2025-09-25 | |
| $56.00 |
Shandong Xuhuang New material CoLTD
|
2025-03-21 | ||
| $1.00 |
VIP7Y
|
Shanghai Longyu Biotechnology Co., Ltd.
|
2024-11-25 | |
| $9.90 |
Wuhan Cell Pharmaceutical Co., Ltd
|
2024-10-23 | ||
| $10.00 |
Wuhan Xinhao Biotechnology Co., Ltd
|
2024-04-02 | ||
| $30.00 |
Shanghai Chinqesen Biotechnology Co., Ltd.
|
2024-03-31 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY